Most Read Articles
30 Apr 2016
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Sep 2015
A 10 to 35 minute time on the scene of cardiac arrest was linked with improved survival of paediatric patients, particularly adolescents, based on an observational study.
01 Sep 2015
Add-on omalizumab is safe and effective in patients with moderate to severe allergic asthma refractory to steroid treatment as shown in a systematic review of three randomised controlled trials.
Kavitha G. Shekar, 01 Aug 2015

Breastfeeding for 6 months or longer may lower the risk of developing childhood leukaemia, a meta-analysis and systematic review has shown.

Perspective on the present and future of colorectal cancer screening

01 Jul 2013
Professor David Lieberman shares his perspective on the present and future of colorectal cancer screening
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Apr 2016
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Sep 2015
A 10 to 35 minute time on the scene of cardiac arrest was linked with improved survival of paediatric patients, particularly adolescents, based on an observational study.
01 Sep 2015
Add-on omalizumab is safe and effective in patients with moderate to severe allergic asthma refractory to steroid treatment as shown in a systematic review of three randomised controlled trials.
Kavitha G. Shekar, 01 Aug 2015

Breastfeeding for 6 months or longer may lower the risk of developing childhood leukaemia, a meta-analysis and systematic review has shown.